Depending on the clinical picture, that typically includes: Relevant baseline bloodwork before starting IGF-1 dynamics where appropriate, so the response can be tracked rather than assumed Glucose and metabolic markers where relevant Follow-up adjustments based on results, tolerability, and goals A clear plan for duration and review rather than indefinite open-ended use This is also why CJC-1295 and Ipamorelin are often discussed alongside related options like Tesamorelin for visceral fat and metabolic goals
Xiaojun M, Min S, Yushan Y, Gaofei R, Jingwen H, Guijun Q
Prostate 78 , 970980 (2018)
Two pills, containing the same medication, made by the same corporation, carrying the same brand name, regulated by the same agency but subject to different standards